Within weeks of graduating from medical school in July 1981, my physician wife and I moved to Philadelphia to begin our internships. Philadelphia seemed a world away from suburban Long Island, New York, where I grew up, but it has been my home for most of my professional life.
Whatever the reason, I’m more reflective these days than ever. Late spring and early summer in Philadelphia was a time for more reflection as our city hosted both the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and The Bio International Convention (BIO) 2015 meeting.
As the healthcare delivery system shifts its focus from “volume” to “value,” it must also change the way executives and physician leaders are paid.
Many private sector reports cross my desk on a regular basis, but rarely does one catch my attention as did “Ahead of the Curve: Top Ten Emerging Health Care Trends: Implications for Patients, Providers, Payers and Pharmaceuticals,” issued by the Academy of Managed Care Pharmacy (AMCP) Foundation.
This editorial is focused on the work of the Pharmacoeconomics and Cost Clinical Effectiveness (PEACE) committee, an important group that I have written about previously.
Much of the focus regarding the implementation of the Affordable Care Act (ACA) has centered on the success (or failure) of healthcare.gov, but other important components of the wide-ranging bill had garnered little attention.
Now that we are solidly into 2015, we should take some time to reflect on a recent special silver anniversary and contemplate what this means for health and healthcare in the next few years. The birthday of the Web is often cited as March 12, 1989. On that date, Sir Tim Berners-Lee produced a document that became the foundation for the Web.
The regular readers of this column know that I am a voracious consumer of private sector reports regarding the healthcare industry. Several recent reports and insights gleaned during my travels across the country have led me to think differently about the ways in which we will purchase healthcare services in the future.
I have had the privilege of serving on the Pharmacy and Therapeutics (P&T) committee at Thomas Jefferson University Hospital for nearly a quarter of a century, and I serve as Chair for its Medication Quality subcommittee.
I am frustrated. Despite more than 2 decades of personal involvement in the public reporting of healthcare outcomes and the widespread dissemination of these reports, there remains very little uptake by consumers of the information reported.
Page 4 of 9
Results 31 - 40 of 83
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME